https://www.selleckchem.com/pr....oducts/bleximenib-ox
vent thromboembolic complications. Orthopedic injury in rodents induced platelet and overall hypercoagulability within 6 hours and fibrinolytic impairment by 12 to 24 hours, mimicking postinjury hypercoagulability in injured patients. This rodent model of orthopedic injury may serve as a preclinical testing ground for potential therapies to mitigate hypercoagulability, maintain normal fibrinolysis, and prevent thromboembolic complications. No agents that are specifically neuroprotective are currently approved to emergently tr
Like
Comment
Share
